Table: Takara Bio -Q1 group results
Aug 6 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2021 Jun 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 15.27 6.94 54.20
(+120.1 pct) (-19.8 pct) (+17.6 pct)
Operating 8.50 693 mln 17.00
(-69.2 pct) (+21.8 pct)
Recurring 8.58 745 mln 17.10
(-66.1 pct) (+20.8 pct)
Net 6.03 404 mln 11.90
(-74.6 pct) (+24.6 pct)
EPS 50.04 yen 3.36 yen 98.82 yen
Ann Div 16.00 yen 20.00 yen
-Q2 div NIL NIL
-Q4 div 16.00 yen 20.00 yen
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T